Small-molecule inhibitor of Fam20C in combination with paclitaxel suppresses tumor growth by LIF-JAK2/STAT3-modulated apoptosis in triple-negative breast cancer-Reference-Cited by-同舟云学术

Small-molecule inhibitor of Fam20C in combination with paclitaxel suppresses tumor growth by LIF-JAK2/STAT3-modulated apoptosis in triple-negative breast cancer

Published:2023-02 Issue: Volume:143 Page:104673
ISSN:1876-1070
Container-title:Journal of the Taiwan Institute of Chemical Engineers
language:en
Short-container-title:Journal of the Taiwan Institute of Chemical Engineers

Author:

Yuan Zhaoxin,Zhen Yongqi,Chen Siwei^ORCID,Li Zixiang,Fu Leilei

Publisher

Elsevier BV

Subject

General Chemical Engineering,General Chemistry

Reference43 articles.

1. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 Countries;Sung;CA Cancer J Clin,2021

2. Triple negative breast cancer (TNBC): non-genetic tumor heterogeneity and immune microenvironment: emerging treatment options;So;Pharmacol Ther,2022

3. Small-molecule drug discovery in triple negative breast cancer: current situation and future directions;Liao;J Med Chem,2021

4. Recent therapeutic trends and promising targets in triple negative breast cancer;Hwang;Pharmacol Ther,2019

5. Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge;Nedeljkovic;Cells,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Immunotherapy and Targeted Therapy of Triple Negative Breast Cancer;Current Pharmaceutical Biotechnology;2024-07-31

2. Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer;International Journal of Molecular Sciences;2023-10-12